Literature DB >> 16685576

Derivative ratio as a measure of effect: sex over age of occurrence of myocardial infarction in Brazil.

Júlio Cesar Rodrigues Pereira1, Laécio Carvalho de Barros.   

Abstract

The concept of relative risk (RR) as an incidence rate ratio is extended to a ratio of derivatives of cumulative occurrences of events with respect to any continuous variable whose domain is partitioned in sub-domains of study and referent groups to be contrasted. RR, thus expressed as a function, allows the identification of key values of the independent variable through which effect, as a relation between sub-domains, is modulated. The effect of sex over age of occurrence of myocardial infarction in a sample of Brazilian patients is analysed. Male sex, as contrasted to female, is acknowledged as a risk factor for the disease but it is known that this risk wanes with aging. Derivatives of cumulative occurrences with respect to age are calculated for men and women. Given the normal distribution of these occurrences, derivatives are found to be very similar to the corresponding normal density functions, with difference not greater than 0.005. This provides an easy way of identifying the derivatives whose ratio is likewise easily calculated. Results suggest that, in the Brazilian sample of patients studied, the greatest men to women RR is 1.9 at the age of 23.5 years and that at the age of 61.2 years risks become evens.

Entities:  

Mesh:

Year:  2006        PMID: 16685576     DOI: 10.1007/s10654-006-0021-y

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  10 in total

Review 1.  The protective effects of estrogen on the cardiovascular system.

Authors:  M E Mendelsohn; R H Karas
Journal:  N Engl J Med       Date:  1999-06-10       Impact factor: 91.245

2.  Global cardiovascular disease prevention: time to get serious.

Authors:  R Beaglehole
Journal:  Lancet       Date:  2001-08-25       Impact factor: 79.321

3.  Hormones for coronary disease-full circle.

Authors:  Jacques E Rossouw
Journal:  Lancet       Date:  2002 Dec 21-28       Impact factor: 79.321

4.  The treatment of coronary heart disease: an update. Part 1: An overview of the risk factors for cardiovascular disease.

Authors:  M Elisaf
Journal:  Curr Med Res Opin       Date:  2001       Impact factor: 2.580

5.  Gender and survival: a population-based study of 201,114 men and women following a first acute myocardial infarction.

Authors:  K MacIntyre; S Stewart; S Capewell; J W Chalmers; J P Pell; J Boyd; A Finlayson; A Redpath; H Gilmour; J J McMurray
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

6.  Prevalence and management of coronary heart disease in primary care: population-based cross-sectional study using a disease register.

Authors:  Kevin Carroll; Azeem Majeed; Caroline Firth; Jeremy Gray
Journal:  J Public Health Med       Date:  2003-03

7.  Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention.

Authors:  Julinda Mehilli; Adnan Kastrati; Josef Dirschinger; Jürgen Pache; Melchior Seyfarth; Rudolf Blasini; Donald Hall; Franz-Josef Neumann; Albert Schömig
Journal:  JAMA       Date:  2002-01-09       Impact factor: 56.272

Review 8.  Sex differences in heart disease incidence and prevalence: implications for intervention.

Authors:  Brandi J Witt; Véronique L Roger
Journal:  Expert Opin Pharmacother       Date:  2003-05       Impact factor: 3.889

9.  Sex differences in evaluation and outcome after stress testing.

Authors:  Véronique L Roger; Steven J Jacobsen; Susan A Weston; Patricia A Pellikka; Todd D Miller; Kent R Bailey; Bernard J Gersh
Journal:  Mayo Clin Proc       Date:  2002-07       Impact factor: 7.616

10.  Risk factors for myocardial infarction in Brazil.

Authors:  Leopoldo S Piegas; Alvaro Avezum; Júlio César R Pereira; João Manoel Rossi Neto; Clóvis Hoepfner; Jorge A Farran; Rui F Ramos; Ari Timerman; José Péricles Esteves
Journal:  Am Heart J       Date:  2003-08       Impact factor: 4.749

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.